Eddie Hickman Stock Analyst Profile - Guggenheim Research Coverage - Stocknear

Eddie Hickman

Stock Analyst at Guggenheim

(4.84)
# 741
Out of 5,506 analysts
19
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

7 Stocks

Name Action PT Current % Upside Ratings Updated
OTLK Outlook Therapeutics
Downgrades: Neutral
n/a
n/a n/a 4 Aug 29, 2025
TARS Tarsus Pharmaceutica...
Maintains: Strong Buy
78 84
65.17 28.89% 8 May 2, 2025
PMN ProMIS Neurosciences
Reiterates: Buy
6 6
n/a n/a 2 Apr 1, 2025
ZVRA Zevra Therapeutics
Maintains: Strong Buy
20 22
9.75 125.64% 1 Mar 13, 2025
GHRS GH Research
Initiates Coverage On: Buy
32
13.1 144.27% 1 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
6.07 476.61% 1 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 May 1, 2023